Table 1 Tumorigenesis in the epigenetic melanoma vaccine model
From: An epigenetic vaccine model active in the prevention and treatment of melanoma
Treatmenta | % AnnexinV+ cells/inocula | Number of mice that developed tumor (total)b | % Tumor-free mice after 40 days |
|---|---|---|---|
Untreated | ~10 | 32 (33) | 3 |
250 nM TSA (24 h) | ~20 | 9 (10) | 10 |
500 nM TSA (24 h) | ~40 | 7 (10) | 30 |
500 nM TSA (48 h) | ~50 | 19 (48) | 61 |